<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38792452</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Symptoms and Conditions in Children and Adults up to 90 Days after SARS-CoV-2 Infection: A Retrospective Observational Study Utilizing the Common Data Model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2911</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13102911</ELocationID><Abstract><AbstractText><b>Background/Objectives:</b> There have been widespread reports of persistent symptoms in both children and adults after SARS-CoV-2 infection, giving rise to debates on whether it should be regarded as a separate clinical entity from other postviral syndromes. This study aimed to characterize the clinical presentation of post-acute symptoms and conditions in the Korean pediatric and adult populations. <b>Methods</b>: A retrospective analysis was performed using a national, population-based database, which was encoded using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). We compared individuals diagnosed with SARS-CoV-2 to those diagnosed with influenza, focusing on the risk of developing prespecified symptoms and conditions commonly associated with the post-acute sequelae of COVID-19. <b>Results</b>: Propensity score matching yielded 1,656 adult and 343 pediatric SARS-CoV-2 and influenza pairs. Ninety days after diagnosis, no symptoms were found to have elevated risk in either adults or children when compared with influenza controls. Conversely, at 1 day after diagnosis, adults with SARS-CoV-2 exhibited a significantly higher risk of developing abnormal liver function tests, cardiorespiratory symptoms, constipation, cough, thrombophlebitis/thromboembolism, and pneumonia. In contrast, children diagnosed with SARS-CoV-2 did not show an increased risk for any symptoms during either acute or post-acute phases. <b>Conclusions</b>: In the acute phase after infection, SARS-CoV-2 is associated with an elevated risk of certain symptoms in adults. The risk of developing post-acute COVID-19 sequelae is not significantly different from that of having postviral symptoms in children in both the acute and post-acute phases, and in adults in the post-acute phase. These observations warrant further validation through studies, including the severity of initial illness, vaccination status, and variant types.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Minjung</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9311-5370</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chaum Life Center, CHA University School of Medicine, Seoul 06062, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Taehee</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9224-6961</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Hae-Ryoung</ForeName><Initials>HR</Initials><Identifier Source="ORCID">0000-0002-2567-2845</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Suyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7790-0160</Identifier><AffiliationInfo><Affiliation>Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Yeongchang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1913-2308</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dong Han</ForeName><Initials>DH</Initials><Identifier Source="ORCID">0000-0003-0175-2012</Identifier><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju 26465, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Sung-Il</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-4085-1494</Identifier><AffiliationInfo><Affiliation>Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health and Environment, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms of COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID condition</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>25</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38792452</ArticleId><ArticleId IdType="pmc">PMC11122571</ArticleId><ArticleId IdType="doi">10.3390/jcm13102911</ArticleId><ArticleId IdType="pii">jcm13102911</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siddiqui S., Alhamdi H.W.S., Alghamdi H.A. Recent Chronology of COVID-19 Pandemic. Front. Public Health. 2022;10:778037. doi: 10.3389/fpubh.2022.778037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.778037</ArticleId><ArticleId IdType="pmc">PMC9114873</ArticleId><ArticleId IdType="pubmed">35602161</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  COVID-19 Dashboard.  [(accessed on 9 April 2024)]; Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Sorg A.-L., Becht S., Jank M., Armann J., von Both U., Hufnagel M., Lander F., Liese J.G., Niehues T., Verjans E. Association of SARS-CoV-2 seropositivity with myalgic encephalomyelitis and/or chronic fatigue syndrome among children and adolescents in Germany. JAMA Netw. Open. 2022;5:e2233454. doi: 10.1001/jamanetworkopen.2022.33454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.33454</ArticleId><ArticleId IdType="pmc">PMC9516317</ArticleId><ArticleId IdType="pubmed">36166227</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F., Belati A., Tulone O., Diella L., Bavaro D.F., Bonica R., Genna V., Smith L., Trott M., Bruyere O., et al. Incidence of long COVID-19 in people with previous SARS-CoV-2 infection: A systematic review and meta-analysis of 120,970 patients. Intern. Emerg. Med. 2023;18:1573&#x2013;1581. doi: 10.1007/s11739-022-03164-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S., Zhao Y., Zeng N., Liu X., Zheng Y., Sun J., Zhong Y., Wu S., Ni S., Gong Y. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: An update. Mol. Psychiatry. 2023;28:4056&#x2013;4069. doi: 10.1038/s41380-023-02171-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02171-3</ArticleId><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino R., Chiappini E., Licari A., Galli L., Marseglia G.L. Prevalence and clinical presentation of long COVID in children: A systematic review. Eur. J. Pediatr. 2022;181:3995&#x2013;4009. doi: 10.1007/s00431-022-04600-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pmc">PMC9476461</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Shafran R., Ladhani S.N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 2022;35:461&#x2013;467. doi: 10.1097/qco.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qco.0000000000000854</ArticleId><ArticleId IdType="pmc">PMC9553244</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J., Moron-Lopez S., Dalmau J., Gonzalez-Aumatell A., Carreras-Abad C., Mendez M., Rodrigo C., Martinez-Picado J. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front. Pediatr. 2022;10:894204. doi: 10.3389/fped.2022.894204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., Bobkova P., Shikhaleva A., El-Taravi Y., Rumyantsev M., Gamirova A., Bairashevskaia A., Petrova P. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z., Leng S., Tascini C., Garg M., Misso K., El Guerche Seblain C., Shaikh N. Risk of long COVID main symptoms after SARS-CoV-2 infection: A systematic review and meta-analysis. Sci. Rep. 2023;13:15332. doi: 10.1038/s41598-023-42321-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Nemati H., Shahisavandi M., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Barzegar Z., Kabiri M., Zeraatpisheh Z., et al. Long COVID in children and adolescents. World J. Pediatr. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., Yu D.H., Baek H., Cho J., You S.C., Park R.W. Data Resource Profile: Health Insurance Review and Assessment Service COVID-19 Observational Medical Outcomes Partnership (HIRA COVID-19 OMOP) database in South Korea. Int. J. Epidemiol. 2024;53:dyae062. doi: 10.1093/ije/dyae062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyae062</ArticleId><ArticleId IdType="pubmed">38658170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho Y., Cho D.Y., Son Y., Lee Y.J., Kim J.W., Lee H.J., You S.C., Park R.W., Lee J.Y. COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications. J. Prev. Med. Public Health. 2021;54:8&#x2013;16. doi: 10.3961/jpmph.20.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.616</ArticleId><ArticleId IdType="pmc">PMC7939755</ArticleId><ArticleId IdType="pubmed">33618494</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W., Kim B.H., Kim M., Kim J., Im M., Ryang S., Kim E.H., Jeon Y.K., Kim S.S., Kim I.J. Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared with levothyroxine alone: A propensity score-matched analysis. Thyroid. 2022;32:764&#x2013;771. doi: 10.1089/thy.2021.0634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2021.0634</ArticleId><ArticleId IdType="pubmed">35570696</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., You S.C., Sena A.G., Kostka K., Abedtash H., Abrah&#xe3;o M.T.F., Alberga A., Alghoul H., Alser O., Alshammari T.M., et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat. Commun. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Jing N., Liu X., Lorman V., Maltenfort M., Schuchard J., Wu Q., Tong J., Razzaghi H., Mejias A., et al. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program. medRxiv. 2022 doi: 10.1101/2022.09.26.22280364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.26.22280364</ArticleId><ArticleId IdType="pmc">PMC10684592</ArticleId><ArticleId IdType="pubmed">38017007</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Tesch F., Batram M., Jacob J., Loser F., Weidinger O., Wende D., Vivirito A., Toepfner N., Ehm F., et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19:e1004122. doi: 10.1371/journal.pmed.1004122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004122</ArticleId><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lee G.M., Razzaghi H., Lorman V., Mejias A., Pajor N.M., Thacker D., Webb R., Dickinson K., Bailey L.C., et al. Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents. JAMA Pediatr. 2022;176:1000&#x2013;1009. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.Y., Kim C., Yu D.H., Park R.W. Safety outcomes of antipsychotics classes in drug-na&#xef;ve patients with first-episode schizophrenia: A nationwide cohort study in South Korea. Asian J. Psychiatry. 2024;91:103857. doi: 10.1016/j.ajp.2023.103857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2023.103857</ArticleId><ArticleId IdType="pubmed">38128353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan You S., Krumholz H.M., Suchard M.A., Schuemie M.J., Hripcsak G., Chen R., Shea S., Duke J., Pratt N., Reich C.G. Comprehensive comparative effectiveness and safety of first-line &#x3b2;-blocker monotherapy in hypertensive patients: A large-scale multicenter observational study. Hypertension. 2021;77:1528&#x2013;1538. doi: 10.1161/HYPERTENSIONAHA.120.16402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16402</ArticleId><ArticleId IdType="pmc">PMC8035236</ArticleId><ArticleId IdType="pubmed">33775125</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T.-H., Huang P.-Y., Wu J.-Y., Chuang M.-H., Hsu W.-H., Tsai Y.-W., Lai C.-C. Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza. BMC Med. 2023;21:480. doi: 10.1186/s12916-023-03200-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03200-2</ArticleId><ArticleId IdType="pmc">PMC10696681</ArticleId><ArticleId IdType="pubmed">38049876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Ehm F., Loser F.L., Vivirito A., Wende D., Batram M., Bechmann L., Buschmann T., Menzer S., Ludwig M. Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent. Res. Sq. 2024 doi: 10.21203/rs.3.rs-3870058/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-3870058/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long COVID outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn K.L., Stukel T.A., Huang A., Abdel-Qadir H., Altaf A., Bell C.M., Cheung A.M., Detsky A.S., Goulding S., Herridge M. Comparison of Medical and Mental Health Sequelae Following Hospitalization for COVID-19, Influenza, and Sepsis. JAMA Intern. Med. 2023;183:806&#x2013;817. doi: 10.1001/jamainternmed.2023.2228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.2228</ArticleId><ArticleId IdType="pmc">PMC10282961</ArticleId><ArticleId IdType="pubmed">37338892</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzam A., Khaled H., Refaey N., Mohsen S., El-Emam O.A., Dawood N., Ahmed H.A., Soliman O.A., Mostafa S., Ramadan H. The burden of persistent symptoms after COVID-19 (long COVID): A meta-analysis of controlled studies in children and adults. Virol. J. 2024;21:16. doi: 10.1186/s12985-024-02284-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02284-3</ArticleId><ArticleId IdType="pmc">PMC10785462</ArticleId><ArticleId IdType="pubmed">38212781</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi W.S. Comprehensive understanding and field application of COVID-19 vaccine. Korean J. Med. 2021;96:155&#x2013;159. doi: 10.3904/kjm.2021.96.3.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjm.2021.96.3.155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi M. Post-viral sequelae of COVID-19 and influenza. Lancet Infect. Dis. 2023;24:218&#x2013;219. doi: 10.1016/S1473-3099(23)00762-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00762-4</ArticleId><ArticleId IdType="pubmed">38104584</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha J.H., Lee J.Y., Choi S.Y., Park S.K. COVID-19 Waves and Their Characteristics in the Seoul Metropolitan Area (Jan 20, 2020&#x2013;Aug 31, 2022) Public Health Wkly. Rep. 2023;16:111&#x2013;136. doi: 10.56786/PHWR.2023.16.5.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.56786/PHWR.2023.16.5.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K., Roel E., Trinh N.T., Mercad&#xe9;-Besora N., Delmestri A., Mateu L., Paredes R., Duarte-Salles T., Prieto-Alhambra D., Catal&#xe0; M. The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis. Nat. Commun. 2023;14:7449. doi: 10.1038/s41467-023-42726-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-42726-0</ArticleId><ArticleId IdType="pmc">PMC10656441</ArticleId><ArticleId IdType="pubmed">37978296</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin M., Lee P., Jang W. An Exploratory Study on Deaths and Changes in Medical Use during the COVID-19 Pandemic. 2021.  [(accessed on 9 April 2024)].  Available online:  https://repository.hira.or.kr/handle/2019.oak/3057.</Citation></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S., Zhang A.X., O&#x2019;Mahoney L.L., Stephenson T.J., Ladhani S., De Stavola B.L., Viner R., Swann O.V. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Li X., Nie J., Tang K., Bhutta Z.A. A systematic review of persistent clinical features after SARS-CoV-2 in the pediatric population. Pediatrics. 2023;152:e2022060351. doi: 10.1542/peds.2022-060351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-060351</ArticleId><ArticleId IdType="pmc">PMC10389775</ArticleId><ArticleId IdType="pubmed">37476923</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner R.M., Ward J.L., Hudson L.D., Ashe M., Patel S.V., Hargreaves D., Whittaker E. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch. Dis. Child. 2021;106:802&#x2013;807. doi: 10.1136/archdischild-2020-320972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320972</ArticleId><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea Law Translation Center  Korea Law Translation Center. Juvenile Act.  [(accessed on 9 April 2024)].  Available online:  https://elaw.klri.re.kr/eng_mobile/viewer.do?hseq=51556&amp;type=sogan&amp;key=9#:~:text=The%20term%20%22juveniles%22%20as%20used,presently%20supervising%20and%20protecting%20juveniles.</Citation></Reference><Reference><Citation>Buonsenso D., Pujol F.E., Munblit D., Pata D., McFarland S., Simpson F.K. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: A survey of 510 children. Future Microbiol. 2022;17:577&#x2013;588. doi: 10.2217/fmb-2021-0285.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T., Pereira S.M.P., Shafran R., De Stavola B.L., Rojas N., McOwat K., Simmons R., Zavala M., O&#x2019;mahoney L., Chalder T. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk A.L., Kuppermann N., Florin T.A., Tancredi D.J., Xie J., Kim K., Finkelstein Y., Neuman M.I., Salvadori M.I., Yock-Corrales A. Post&#x2013;COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw. Open. 2022;5:e2223253. doi: 10.1001/jamanetworkopen.2022.23253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I., Smane L., Kivite-Urtane A., Pucuka Z., Racko I., Klavina L., Pavare J. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front. Pediatr. 2021;9:752385. doi: 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S.K., Nielsen S.D., Nygaard U., Bundgaard H., Palm P., Rotvig C., Christensen A.V. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022;6:240&#x2013;248. doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnachie E., Hapfelmeier A., Linde K., Tauscher M., Gerlach R., Greissel A., Schneider A. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: A retrospective cohort study using routinely collected claims data. BMJ Open. 2022;12:e064979. doi: 10.1136/bmjopen-2022-064979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-064979</ArticleId><ArticleId IdType="pmc">PMC9511014</ArticleId><ArticleId IdType="pubmed">36137635</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M., Ireland G., Amin-Chowdhury Z., Ramsay M.E., Ladhani S.N. Acute and persistent symptoms in children with polymerase chain reaction (PCR)&#x2013;confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with test-negative children in England: Active, prospective, national surveillance. Clin. Infect. Dis. 2022;75:e191&#x2013;e200. doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I. Long COVID-19 is rarely diagnosed in children: Nationwide register-based analysis. Arch. Dis. Child. 2023;108:151. doi: 10.1136/archdischild-2022-324998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-324998</ArticleId><ArticleId IdType="pubmed">36368772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossley C.J., Kavaliunaite E., Harman K., Cook J., Ruiz G., Gupta A. Post-acute COVID-19 outcomes in children requiring hospitalisation. Sci. Rep. 2022;12:8208. doi: 10.1038/s41598-022-12415-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-12415-x</ArticleId><ArticleId IdType="pmc">PMC9113067</ArticleId><ArticleId IdType="pubmed">35581348</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., Ellermann-Eriksen S., Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children-a nationwide cohort study. Eur. J. Pediatr. 2022;181:1597&#x2013;1607. doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont R., Richard V., Lorthe E., Loizeau A., Pennacchio F., Zaballa M.-E., Baysson H., Nehme M., Perrin A., L&#x2019;Huillier A.G. A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents. Nat. Commun. 2022;13:7086. doi: 10.1038/s41467-022-34616-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34616-8</ArticleId><ArticleId IdType="pmc">PMC9708639</ArticleId><ArticleId IdType="pubmed">36446760</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A., Janda A., Renk H., Stich M., Frieh P., Kaier K., Lohrmann F., Nieters A., Willems A., Huzly D. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine. 2022;84:104245. doi: 10.1016/j.ebiom.2022.104245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov I.M., Spiridonova E., Bobkova P., Gamirova A., Shikhaleva A., Andreeva M., Blyuss O., El-Taravi Y., DunnGalvin A., Comberiati P. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch. Dis. Child. 2021;106:429&#x2013;439. doi: 10.1136/archdischild-2020-320338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320338</ArticleId><ArticleId IdType="pubmed">33262177</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingappan K., Karmouty-Quintana H., Davies J., Akkanti B., Harting M.T. Understanding the age divide in COVID-19: Why are children overwhelmingly spared? Am. J. Physiol.-Lung Cell. Mol. Physiol. 2020;319:L39&#x2013;L44. doi: 10.1152/ajplung.00183.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00183.2020</ArticleId><ArticleId IdType="pmc">PMC7324935</ArticleId><ArticleId IdType="pubmed">32491949</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusenza F., Davino G., D&#x2019;Alvano T., Argentiero A., Fainardi V., Pisi G., Principi N., Esposito S. Silence of the lambs: The immunological and molecular mechanisms of COVID-19 in children in comparison with adults. Microorganisms. 2021;9:330. doi: 10.3390/microorganisms9020330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020330</ArticleId><ArticleId IdType="pmc">PMC7915740</ArticleId><ArticleId IdType="pubmed">33562210</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C., Chen W., Cai J., He Y. The mechanisms of milder clinical symptoms of COVID-19 in children compared to adults. Ital. J. Pediatr. 2024;50:28. doi: 10.1186/s13052-024-01587-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-024-01587-z</ArticleId><ArticleId IdType="pmc">PMC10865718</ArticleId><ArticleId IdType="pubmed">38355623</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>